Monitoring Platelet Function During Continuous Hemodialysis
Changes in Platelet Function During Continuous Veno-venous Hemodialysis Using the Multiplate Device
1 other identifier
observational
50
1 country
1
Brief Summary
Aim of the study is a description of changes in platelet function during continuous veno-venous hemodialysis or hemofiltration in patients on an intensive care unit using the Multiplate system.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2012
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2012
CompletedFirst Submitted
Initial submission to the registry
April 16, 2013
CompletedFirst Posted
Study publicly available on registry
April 23, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2013
CompletedMarch 3, 2017
March 1, 2017
8 months
April 16, 2013
March 2, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
ASPItest
Area under the aggregation curve (AUC) after platelet stimulation with arachidonic acid at baseline and 6, 12, 24 and 48 hours after the start of the continuous hemofiltration.
Baseline, 6, 12, 24 and 48 hours
Secondary Outcomes (4)
ADPtest
Baseline, 6, 12, 24 and 48 hours
TRAPtest
Baseline, 6, 12, 24, 48 hours
CT-INTEM
Baseline, 6, 12, 24 and 48 hours
MCF-INTEM
Baseline, 6, 12, 24 and 48hours
Other Outcomes (8)
Age
Baseline
Height
Baseline
Weight
Baseline
- +5 more other outcomes
Study Arms (1)
Dialysis
Platelet function will be documented during the first 48 hours of veno-venous hemofiltration using the Multiplate system.
Eligibility Criteria
Patients in an intensive care unit with the need for a renal replacement therapy-
You may qualify if:
- Need for a continuous renal replacement therapy
- Platelet Count \>100.000/nl
You may not qualify if:
- Pregnancy
- Age \<18 years
- Renal replacement therapy within the 7 days prior to enrollment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Johann Wolfgang Goethe-University
Frankfurt am Main, Hesse, 60590, Germany
Related Publications (1)
Daugirdas JT, Bernardo AA. Hemodialysis effect on platelet count and function and hemodialysis-associated thrombocytopenia. Kidney Int. 2012 Jul;82(2):147-57. doi: 10.1038/ki.2012.130. Epub 2012 May 16.
PMID: 22592187BACKGROUND
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr. med Saskia Wand
Study Record Dates
First Submitted
April 16, 2013
First Posted
April 23, 2013
Study Start
December 1, 2012
Primary Completion
August 1, 2013
Study Completion
August 1, 2013
Last Updated
March 3, 2017
Record last verified: 2017-03